Genomics biomarker good practice consultation
The European Medicines Agency (EMA) has produced a concept paper for consultation on good practice in the use of genomic data and biomarkers in medicines development and safety monitoring. Responses to the consultation should be sent to email@example.com. The closing date for submissions is 31 October 2014.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066079
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com